Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prototype antiepileptic drug clinical development plan

L D Kramer1, G W Pledger, M Kamin

  • 1R. W. Johnson Pharmaceutical Research Institute, Spring House, Pennsylvania 19477.

Epilepsia
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-omics analysis of antiviral interactions of Elizabethkingia anophelis and Zika virus.

Scientific reports·2024
Same author

Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease.

The journal of prevention of Alzheimer's disease·2023
Same author

Reservoir hosts experiencing food stress alter transmission dynamics for a zoonotic pathogen.

Proceedings. Biological sciences·2021
Same author

International Journal of Infectious Diseases: from the past quarter-century to the next.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2021
Same author

Editorial: An Industry Perspective: Future of Anti-Amyloid Trials.

The journal of prevention of Alzheimer's disease·2020
Same author

The vector ecology of introduced Culex quinquefasciatus populations, and implications for future risk of West Nile virus emergence in the Galápagos archipelago.

Medical and veterinary entomology·2018

Developing new antiepileptic drugs (AEDs) is challenging. This study presents an innovative clinical trial plan to overcome regulatory hurdles and improve the development of novel AEDs for epilepsy treatment.

Area of Science:

  • Neurology
  • Clinical Pharmacology
  • Drug Development

Background:

  • Antiepileptic drug (AED) development faces significant challenges, including stringent regulatory demands for efficacy and safety.
  • Traditional clinical trial designs and physician beliefs can impede the progress of new AEDs.
  • U.S. Food and Drug Administration (FDA) regulations require robust proof of safety and effectiveness for market approval.

Purpose of the Study:

  • To present an innovative clinical development plan for antiepileptic drugs (AEDs).
  • To address regulatory requirements and overcome hurdles in AED development.
  • To explore alternative endpoints and compare various trial designs for AEDs.

Main Methods:

  • The study outlines a model clinical development plan incorporating innovative trial designs.

Related Experiment Videos

  • It discusses the use of alternative endpoints to assess drug efficacy and safety.
  • The plan considers three key clinical contexts: adjunct therapy, AED substitution, and monotherapy.

    • Main Results:

    • The proposed plan addresses the rigorous requirements for demonstrating AED efficacy and safety.
    • Innovations in trial design are highlighted to facilitate drug development.
    • The plan is applicable across different therapeutic strategies for epilepsy management.

    Conclusions:

    • The presented clinical development plan offers a strategic approach to navigating AED development challenges.
    • This innovative model aims to streamline the process of bringing new antiepileptic drugs to market.
    • The plan supports the evaluation of AEDs in diverse clinical scenarios, enhancing treatment options for epilepsy.